Verrill Welcomes Jeffrey A. Smagula, Experienced Health Care and Life Sciences Attorney, Former Health Plan Compliance Executive

May 12, 2021 Press Releases

(May 12, 2021) – Verrill is pleased to welcome Jeffrey A. Smagula to the firm’s Boston office as Counsel in its nationally recognized Health Care & Life Sciences Group.

Jeff Smagula brings to Verrill years of industry experience he gained while serving in key posts at a global life sciences company and most recently at one of the top three health insurance plans in Massachusetts. He has deep experience with U.S. and international privacy regulations, export and trade compliance, Foreign Corrupt Practices Act compliance, provider reimbursement and health insurance, as well as the design, implementation, and operation of sophisticated compliance systems. From his in-house positions and through experience gained as a junior partner at the Boston office of a global law firm, Jeff dealt with an array of federal, state, and international administrative and regulatory agencies to help clients achieve their business and strategic objectives. With this background, Jeff Smagula is also uniquely positioned to assist clients confronting a variety of legal compliance risks and design by developing and enhancing legal compliance and privacy programs for participants in the health care and life sciences industries.

“We are delighted to welcome Jeff to our Health Care & Life Sciences Group,” said Michael K. Fee, Chair of Verrill’s Health Care & Life Sciences Group. “Jeff’s knowledge and experience in important areas such as domestic and international privacy regulations, complement and expand the reach of our talented team of lawyers serving the health care and life sciences industries, allowing us to continue providing innovative, responsive and cost-effective services and solutions to our clients, and meet their constantly-evolving needs. Consistent with Verrill’s longstanding commitments, Jeff also has proven himself to be a leader and champion of diversity, inclusion, equity and opportunity in the workplace and beyond,” Fee added.

Most recently, Jeff Smagula was Vice President, Chief Compliance and Ethics Officer at Tufts Health Plan and prior to that he served as Head of Trade Compliance and Assistant General Counsel at EMD Millipore Corporation. Jeff began his legal career as a member of the Litigation Department and Government Investigations Practice Group at WilmerHale LLP and while at the firm worked for six months as a Special Assistant District Attorney at the Middlesex County District Attorney’s Office.

Jeff earned a Bachelor of Arts degree with honors from Harvard College and a Juris Doctor with honors from the Georgetown University Law Center.

Firm Highlights


European Union GDPR—Institution

Counseled a preeminent health system and academic medical center on its compliance with the European Union General Data Protection Regulation (GDPR) in relation to its clinical and research activities, including its international research studies...


Verrill Ranked in American Bar Association’s Health Law Top 10 in the Northeast

(January 19, 2021) – Verrill was recently ranked third in the American Bar Association (ABA) Health Law Section's Eighth Annual Top 10 Recognition for the Northeast Region. This is the sixth consecutive year that...


Common Rule

Guided multiple clients through the implementation of the revised HHS regulations (the "Common Rule"), including reviewing and revising policies and procedures, and assisting with institutional approaches to implementation.


Verrill Welcomes Health Care Attorney Alicia Siani

(February 2, 2021) – Verrill is pleased to welcome health care attorney Alicia Siani to the firm’s Boston, Massachusetts office. Siani represents clients in a wide range of regulatory issues, including HIPAA privacy matters...


Multi-Site Global Research

Developed and negotiated site and coordinating center agreements in connection with a multi-site, international, National Institutes of Health (NIH)-funded study, and advised on regulatory issues related to the conduct of the study and subsequent...


HHS Confirms Providers’ Right to 340B Discount Pricing for Contract Pharmacies

As a holiday gift to providers, the U.S. Department of Health and Human Services (HHS) General Counsel recently issued a strongly worded Advisory Opinion indicating that federal law requires drug manufacturers to deliver covered...


The Regulatory Sprint is Over - What’s at the Finish Line Under the New Stark and AKS Final Rules?

The U.S. Department of Health and Human Services (HHS) completed its “Regulatory Sprint” by finalizing changes to regulations pertaining to two federal fraud and abuse laws. On December 2, 2020, the Centers for Medicare...


Massachusetts Health Care Bill Makes Several Significant Changes

While you were celebrating the New Year, Governor Baker signed Chapter 260 of the Acts of 2020, an “Act promoting a resilient health care system that puts patients first,” the result of the Legislature’s...


Fraud and Abuse Investigations Handbook for the Health Care Industry, Second Edition.

Health care attorney Paul Shaw co-authored Fraud and Abuse Investigations Handbook for the Health Care Industry, Second Edition with Robert Griffith, published by the American Health Law Association (AHLA). Paul and Robert provide legal...


Conflicts of Interest

Reviewed medical center's systems, policies and procedures for identifying, assessing, and managing investigator and institutional conflicts of interest.

Contact Verrill at (855) 307 0700